C57.8 — Malignant neoplasm of overlapping sites of female genital organs

Billable

Is C57.8 billable?

Yes — C57.8 is billable for FY2027. C57.8 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C57.8 may be submitted for encounters from October 1, 2026 through September 30, 2027.

C57.8 at a glance

Code	C57.8
Description	Malignant neoplasm of overlapping sites of female genital organs
Billable	Yes
Code set	ICD-10-CM FY2027
Valid for encounters	October 1, 2026 – September 30, 2027

Which MS-DRGs does C57.8 group to?

C57.8 sits in MDC 13 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

731Uterine and Adnexa Procedures for Malignancy with MCCsurgical
732Uterine and Adnexa Procedures for Malignancy with CCsurgical
733Uterine and Adnexa Procedures for Malignancy without CC/MCCsurgical

Inclusion terms

Alternative wording in documentation that is classified to C57.8.

Primary malignant neoplasm of two or more contiguous sites of the female genital organs whose point of origin cannot be determined
Primary tubo-ovarian malignant neoplasm whose point of origin cannot be determined
Primary utero-ovarian malignant neoplasm whose point of origin cannot be determined

How long has C57.8 existed?

C57.8 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.